Talking Precision Medicine Podcast

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

April 2, 2019
Building trust in rare disease with Julie Walters | Podcast #09
March 5, 2019
Standing up the Alliance for AI in Healthcare with Annastasiah Mhaka | Podcast #08
February 19, 2019
Modeling systems from organoids to EHRs with Olivier Elemento | Podcast #07
February 5, 2019
Where were you when the FDA approved CAR-T? with Patrick Hanley | Podcast #06
January 22, 2019
Long on evidence, strong on science with Matthew Michelson | Podcast #05
January 8, 2019
The organic intelligence of families in need with Ethan Perlstein | Podcast #04
December 19, 2018
The data-driven storyteller with Elia Stupka | Podcast #03
December 12, 2018
AI could be made illegal tomorrow with Jonny Wray | Podcast #02
November 28, 2018
AI, it’s all about the drugs with Asim Siddiqui | Podcast #01

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.